Citations

 

 1          Social networks and quality of life in breast cancer

*Kroenke CH, Kwan ML, Neugut AI, Ergas IJ, Wright JD, Caan BJ, Hershman D, Kushi LH. Social networks, social support mechanisms, and quality of life after breast cancer diagnosis. Breast Cancer Research and Treatment  2013.[CHK1] 

2          How social networks may influence cancer outcomes

Kroenke, Candyce. A conceptual model of social networks and mechanisms of cancer mortality, and potential strategies to improve survival. Translational Behavioral Medicine 2018.[CHK2] 

3          Social isolation and breast cancer survival

* Kroenke CH, Kubzansky LD, Schernhammer ES, Holmes MD, Kawachi I. Social Networks, Social Support, and Survival After Breast Cancer Diagnosis. Journal of Clinical Oncology 2006.[CHK3] 

4          Quality of life, social well-being, and breast cancer outcomes

Epplein M, Zheng Y, Zheng W, Chen Z, Gu K, Penson D, Lu W, Shu XO. Quality of life after breast cancer diagnosis and survival. Journal of Clinical Oncology 2011.

5          Strayhorn SM, Bergeron NQ, Strahan DC, Villines D, Fitzpatrick V, Watson KS, Khanna A, Molina Y. Understanding the relationship between positive and negative social support and the quality of life among African American breast cancer survivors. Support Care Cancer. September 2021.

6           Pinquart M, Duberstein PR. Associations of social networks with cancer mortality: a meta-analysis. Crit Rev Oncol Hematol. 2010 Aug

7          Morey BN, Valencia C, Park HW, Lee S. The central role of social support in the health of Chinese and Korean American immigrants. Soc Sci Med. 2021 September?

8          Healthy People 2020. Washington, DC: U.S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion. May 6, 2020.

9          Shelton RC, Clarke Hillyer G, Hershman DL, et al. . Interpersonal influences and attitudes about adjuvant therapy treatment decisions among non-metastatic breast cancer patients: an examination of differences by age and race/ethnicity in the BQUAL study. Breast Cancer Res Treat. 2013;137(3):817–828. 

10        Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57–70.

11        Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674.

12        Lutgendorf SK, Sood AK, Anderson B, McGinn S, Maiseri H, Dao M, Sorosky JI, De Geest K, Ritchie J, Lubaroff DM. Social support, psychological distress, and natural killer cell activity in ovarian cancer. J Clin Oncol. 2005 Oct 1;23(28):7105-13.

13         Heer K, Kumar H, Read JR, Fox JN, Monson JR, Kerin MJ. Serum vascular endothelial growth factor in breast cancer: its relation with cancer type and estrogen receptor status. Clin Cancer Res. 2001;7(11):3491–3494.

14         Gasparini G. Prognostic value of vascular endothelial growth factor in breast cancer. Oncologist. 2000;5(Suppl 1):37–44.

15         Liu Y, Tamimi RM, Collins LC, et al. . The association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy: results from the Nurses’ Health Study. Breast Cancer Res Treat. 2011;129(1):175–184. 

16         Bendardaf R, Buhmeida A, Hilska M, et al. . VEGF-1 expression in colorectal cancer is associated with disease localization, stage, and long-term disease-specific survival. Anticancer Res. 2008;28(6B):3865–3870.

17         Lutgendorf SK, Garand L, Buckwalter KC, Reimer TT, Hong SY, Lubaroff DM. Life stress, mood disturbance, and elevated interleukin-6 in healthy older women. j Gerontol a Biol Sci Med Sci. 1999;54(9):M434–M439.

18         Kroenke CH, Hankinson SE, Schernhammer ES, Colditz GA, Kawachi I, Holmes MD. Caregiving stress, endogenous sex steroid hormone levels, and breast cancer incidence. Am j Epidemiol. 2004;159(11):1019–1027.

19         Grivennikov SI, Karin M. Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage. Ann Rheum Dis. 2011;70(Suppl 1):i104–i108.

20         Guthrie GJ, Roxburgh CS, Horgan PG, McMillan DC. Does interleukin-6 link explain the link between tumour necrosis, local and systemic inflammatory responses and outcome in patients with colorectal cancer? Cancer Treat Rev. 2013;39(1):89–96.